v3.25.1
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2024
Mar. 31, 2025
Jun. 28, 2024
Document Information [Line Items]      
Entity Central Index Key 0001625101    
Entity Registrant Name Pulse Biosciences, Inc.    
Amendment Flag true    
Current Fiscal Year End Date --12-31    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2024    
Document Transition Report false    
Entity File Number 001-34899    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 46-5696597    
Entity Address, Address Line One 601 Brickell Key Drive, Suite 1080    
Entity Address, City or Town Miami    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33131    
City Area Code 510    
Local Phone Number 906-4600    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol PLSE    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 182,956,030
Entity Common Stock, Shares Outstanding   67,273,800  
Amendment Description The Company is filing this Amendment No. 1 (“Amendment”) to its Annual Report on Form 10‑K for the fiscal year ended December 31, 2024, originally filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2025 (the “Original Filing”), for the purpose of providing the information required by Items 10, 11, 12, 13, and 14 of Part III of Form 10-K. This information was previously omitted from the Original Filing in reliance on General Instruction G(3) to the Annual Report on Form 10-K, which permits the above-referenced Items to be incorporated in the Annual Report on Form 10-K by reference from a definitive proxy statement, if such definitive proxy statement is filed no later than 120 days after December 31, 2024.